November 25, 2024 / 11:34 IST
Reported Standalone quarterly numbers for Parmax Pharma Ltd. are:Net Sales at Rs 9.28 crore in September 2024 up 128.05% from Rs. 4.07 crore in September 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.22 crore in September 2024 up 84.14% from Rs. 1.37 crore in September 2023.
EBITDA stands at Rs. 0.31 crore in September 2024 up 140.79% from Rs. 0.76 crore in September 2023.
| Parmax Pharma Ltd. | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'24 | Jun'24 | Sep'23 | | Net Sales/Income from operations | 9.28 | 7.82 | 4.07 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 9.28 | 7.82 | 4.07 | | EXPENDITURE | | Consumption of Raw Materials | 7.44 | 6.17 | 1.38 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.03 | -0.31 | 1.35 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.82 | 0.75 | 0.85 | | Depreciation | 0.40 | 0.40 | 0.43 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.85 | 0.69 | 1.25 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.20 | 0.12 | -1.20 | | Other Income | 0.12 | 0.01 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -0.09 | 0.12 | -1.19 | | Interest | 0.13 | 0.11 | 0.18 | | P/L Before Exceptional Items & Tax | -0.22 | 0.01 | -1.37 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.22 | 0.01 | -1.37 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -0.22 | 0.01 | -1.37 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.22 | 0.01 | -1.37 | | Equity Share Capital | 3.74 | 3.74 | 3.74 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.58 | 0.03 | -3.66 | | Diluted EPS | -0.58 | 0.03 | -3.66 | | EPS After Extra Ordinary | | Basic EPS | -0.58 | 0.03 | -3.66 | | Diluted EPS | -0.58 | 0.03 | -3.66 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
